Hey there, money mavens! 🌟 Let's talk about making smart investments, especially in the world of dividend stocks. Picture this: you're sipping a refreshing...
DETROIT, Aug. 8, 2025 /PRNewswire/ -- American Axle & Manufacturing Holdings, Inc. (AAM), (NYSE: AXL) will participate in the J.P. Morgan 2025 Auto Conference...
Luxury Retailer Elevates Customer Service Experience with Patented NLX Technology that Combines Voice, Chat and Visuals using Amazon Bedrock and Amazon Connect
NEW YORK, Aug....
AUSTIN, Texas, Aug. 7, 2025 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, today announced its participation in upcoming investor...
TORTOLA, British Virgin Islands, Aug. 7, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN), a leading stablecoin infrastructure provider with its flagship product stablecoin WUSD,...
Alright, babes, let's dive into the fabulous world of Berkshire Hathaway's stock portfolio! We're about to uncover two standout gems that are just too...
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza will be participating a virtual fireside chat hosted by Piper Sandler senior research analyst Yasmin Rahini on August 7, 2025 at 11:00amEST.
SUGAR LAND, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI) (“AOI”), a leading provider of advanced optical and HFC networking products that power the internet, today announced the Company will virtually present via a fireside chat format at the following investor conference:
Hey there, my fabulous financial fashionistas! Ready to dive into some juicy money wisdom that’ll have you strutting towards wealth like you own Wall...
BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza will be participating a virtual fireside chat hosted by Truist Securities analyst Joon Lee on August 5, 2025 at 10:00amEST.